The Boston Globe writes about Professor Sangeeta Bhatia's commitment to mentoring her students. “It's heartening to know that, tucked away in labs all over our region, solution-driven scientists like Sangeeta Bhatia are tinkering and building — and encouraging others to do the same.”
Boston Globe reporter Chris Reify writes that Professor Sangeeta Bhatia has been awarded the 2014 $500,000 Lemelson-MIT Prize. “Dr. Bhatia is a wonderful example of a woman who has used her brilliance, skill and creativity to radically improve the detection and treatment of serious global health issues,” says Dorothy Lemelson, Lemelson Foundation chair.
NBC News reports that MIT Prof. Sangeeta Bhatia has been awarded the Lemelson-MIT prize for her work designing miniaturized biomedical tools. "As innovations emerge, we're constantly asking whether they can be repurposed for one of the two diseases we concentrate on: liver disease and cancer,” says Bhatia.
“There are now 108 known places in the genome which point us towards genes that are involved in causation. And, as you suggest, while most are in the nervous system, some of them, very intriguingly, point to the immune system as being involved,” Dr. Steven Hyman says of the new findings on schizophrenia during an interview with the PBS Newshour.
Los Angeles Times reporter Geoffrey Mohan writes about a new study, coauthored by researchers from the Broad Institute, that identifies over 100 regions in human DNA that correlate with schizophrenia. “The findings provide substantial support for a genetic root to the disorder and greatly narrow the search for genes that may cause the disease, the authors said,” writes Mohan.
“In the largest-ever donation to psychiatric research, Connecticut businessman Ted Stanley is giving $650 million to the Eli and Edythe Broad Institute of MIT and Harvard,” reports Curt Nickisch for WBUR.
New York Times reporter Gina Kolata examines new findings from researchers at the Broad Institute that provide evidence that triglycerides are a cause of heart attacks.
Joel Brown reports for The Boston Globe on the new Innovations of Cambridge tour, which features several research labs at MIT. “It leaves them with the feeling that they’ve experienced MIT in a way that the casual person wandering the streets would not,” explains guide Daniel Berger-Jones.
New York Times reporter Gina Kolata examines a new MIT study that uncovered a rare mutation that protects people from getting Type 2 diabetes. The findings could be applied to developing a drug that mimics how the mutation operates, Kolata writes.